Sustainability & Climate

Biotech firm Bright Minds Biosciences closes a massive $175M deal, fueling its race to develop novel drugs for epilepsy and rare neurological conditions.

As the ENA Foundation marks 35 years, new chair Kimberly Russo, a former scholarship recipient, unveils a vision to bolster a strained emergency nursing workforce.

City councillors, labour unions, and community groups plan a major counter-rally to defend Toronto's diversity against rising xenophobia and a protest.

Corvias Foundation opens its annual scholarship for employee children, a strategic investment in its workforce that makes higher education more accessible.

A new $50M venture fund from Penn, BioNTech, and OUP aims to turn the university's breakthrough research into life-saving therapies faster than ever.

A top luxury planner is trading Zoom calls for Swiss Alps adventures, letting couples "test-drive" their destination wedding before they say "I do."

With a new board appointment and $19M in funding, Enhanced Genomics is leveraging its 3D genomics platform to build its own pipeline of precision therapies.

After resolving manufacturing hurdles, Camurus' self-administered acromegaly treatment Oclaiz is back on track for US approval, promising new hope for patients.

Prescient's acquisition of Uptake creates an integrated giant in healthcare consulting. What does this mean for the industry, clients, and patient outcomes?

Private equity giant Platinum Equity invests in century-old Norton Packaging, signaling a major growth push in the resilient rigid packaging sector.

With new funding, Major Medical Devices is advancing a novel AAA repair device that uses arm access, promising safer procedures and wider patient eligibility.

Akari Therapeutics is advancing a new class of cancer drugs. Its unique PH1 payload kills tumors and activates the immune system, setting up a pivotal 2026.

With a new $1.6B valuation led by T. Rowe Price, Hadrian is scaling its AI-powered factories to spearhead America's industrial and defense resurgence.

A new collaboration between the Global Alzheimer's Platform and Alamar Biosciences aims to revolutionize diagnosis with ultra-sensitive blood tests for all.

Newly-formed materials giant Magnera reports Q1 results on Feb 5. Investors eye its path to profitability while the industry watches for key market signals.

A new report reveals 10 proven ways to fix the critical mental health gap for trafficking survivors, as 75% call it their most urgent need.

Modest growth is forecast, but Canada's economy faces a pivotal year as federal stimulus clashes with looming CUSMA renegotiations and U.S. headwinds.

As Mammoth Biosciences preps for JPM, its ultracompact CRISPR tech aims to redefine in vivo gene therapy, promising cures for diseases beyond the liver.

Raleigh-based Attindas Hygiene Partners acquires 53-year-old Italian firm SILC, a strategic move to capture a larger share of Europe's booming hygiene market.

The Oncology Institute promotes new CIO and CPO, signaling a strategic push into AI-driven care and robust talent management to dominate the market.